Top Markets
#1 Islamic Coin Islamic Coin +151.51%
#2 Akedo Akedo +65.07%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +50.07%
#5 Velvet Velvet +44.04%
#6 Black Phoenix Black Phoenix +34.24%
#7 Cross Cross +27.93%
#8 Cap Cap +17.71%
#9 DoubleZero DoubleZero +14.64%
#10 Pieverse Pieverse +10.18%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Exopharm Limited Exopharm Limited

Exopharm Limited

EX1
Classement en actions #39131
Exopharm Limited is an Australian clinical-stage firm dedicated to developing... Exopharm Limited is an Australian clinical-stage firm dedicated to developing groundbreaking therapeutics utilizing extracellular vesicles (EVs). Its core technologies include an extracellular vesicle positioning system (EVPS), which facilitates the precise targeting of exosomes by attaching specific molecules to their surface, guiding them to particular tissues or cell types. Another innovation is oligonucleotide packing, designed to optimize therapeutic delivery by preferentially loading specific RNA molecules into exosomes as medicinal cargo. Additionally, Exopharm employs ligand-based exosome affinity purification for effectively isolating and refining exosomes from biological fluids such as blood and cell culture media. The company's engineered EV product portfolio features Fortrexo CoV, aimed at treating SARS-CoV-2 infections; Cognevo, developed for neurodegenerative diseases; and PlexoDox, intended for cancer treatment. Exopharm Limited also maintains a research collaboration with Showa Denko Materials Co., Ltd. The company was founded in 2013 and is headquartered in Melbourne, Australia.
Prix de l'action
$0.00700343
Dernière synchronisation: 2023-10-30
Capitalisation boursière
$637.31K
Changement (1 jour)
0.50%
Changement (1 an)
0.00%
Pays
AU
Échange Exopharm Limited (EX1)

Catégorie

Healthcare
Le prix EX1 avec la capitalisation boursière de B
Exopharm Limited Exopharm Limited
EX1
$0.00700343
Capitalisation boursière de Exopharm Limited(EX1)
Capitalisation boursière: $637.31K
En August 2026, Exopharm Limited a une capitalisation boursière de $637.31K. Cela fait de Exopharm Limited la 39131st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Exopharm Limited du 2018 au 2026
EX1 par rapport au top 5 des plus populaires stocks
Prix pour EX1 L’actif B La capitalisation boursière de B Résultats
Exopharm Limited Exopharm Limited
$60,104.81 $637.31K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +858,220,126.04%
Exopharm Limited Exopharm Limited
$49,088.70 $637.31K
Apple Inc. Apple Inc.
AAPL
$4.467T +700,924,002.44%
Exopharm Limited Exopharm Limited
$45,872.38 $637.31K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +654,999,089.40%
Exopharm Limited Exopharm Limited
$40,660.19 $637.31K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +580,575,684.25%
Exopharm Limited Exopharm Limited
$31,366.40 $637.31K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +447,872,231.48%